Xubin Li, PhD^1*, Kartik Singhal^2*, Qing Deng, PhD^3*, Dai Chihara, MD, PhD⁴, David A Russler-Germain, MD, PhD⁵, Usama Hussein^1*, Jennifer Ann Foltz, PhD^6*, Jared Henderson, PhD^7*, Ashley Wilson^7*, Evelyn Schmidt^8*, Imran A. Nizamuddin, MD⁹, Tommy Dinh^1*, Ryan Sun^10*, Akhil Kesaraju, BA^11*, Laura K. Hilton, PhD^12*, David W. Scott, MBChB, PhD¹³, Francisco Vega, MD, PhD¹⁴, Christopher R. Flowers, MD, MS⁴, Obi Griffith, PhD^6*, Todd A Fehniger¹⁵, Malachi Griffith, PhD^6* and Michael R R. Green, PhD¹⁶

¹University of Texas MD Anderson Cancer Center, Houston, TX
²Washington University St. Louis, St Louis, MO
³Department of Lymphoma & Myeloma, The University of Texas at MD Anderson Cancer, Houston, TX
⁴Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Saint Louis, MO
⁶Washington University School of Medicine in St. Louis, St Louis, MO
⁷The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Washington University St. Louis, St. Louis
⁹Division of Oncology, Washington University School of Medicine, St. Louis, MO
¹⁰Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Washington University School of Medicine in St. Louis, Saint Louis, MO
¹²Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
¹³Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada
¹⁴MD Anderson Cancer Center, Houston, TX
¹⁵Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
¹⁶Department of Lymphoma/Myeloma, Friendswood, TX

Koorosh Korfi, PhD¹, Sabine Wilson, PhD^2*, Zhiwen Jiang, PhD^3*, Ailsa Christiansen, PhD^4*, Sreenath Krishnan^3*, Candice Jamois, PharmD^3*, Annika Blank, PhD^5*, Alexandra Epp^6*, Abraham Silva^6*, Philip Knuckles^3*, Joanne Hayward^4*, Johannes Sam, PhD^5*, Katharina Lechner^7*, Natalie Dimier, PhD^8*, Paolo F. Caimi⁹, Lorenzo Falchi, MD¹⁰, Giuseppe Gritti, MD, PhD^11*, Franck Morschhauser, phd¹², Martin Hutchings, MD, PhD¹³, Michael J. Dickinson, MBBS, DMedSci¹⁴ and Carmelo Carlo-Stella, MD¹⁵

¹Pharma Research and Early Development, Innovation Center Zürich, Roche, Zürich, Switzerland
²Pharma Research and Early Development, Roche Innovation Center Welwyn, Roche, Welwyn, United Kingdom
³Pharma Research and Early Development, Roche Innovation Center Basel, Roche, Basel, Switzerland
⁴A4P Consulting Ltd, Sandwich, United Kingdom
⁵Pharma Research and Early Development, Roche Innovation Center Zurich, Roche, Schlieren, Switzerland
⁶Pharma Research and Early Development, Roche Innovation Center Munich, Roche, Penzberg, Germany
⁷Pharma Research and Early Development, Innovation Center Munich, Roche, Munich, Germany
⁸Pharma Research and Early Development, Innovation Center Welwyn, Roche, Welwyn, United Kingdom
⁹Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
¹⁰Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Hematology and BMT Unit, ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy
¹²Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France
¹³Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
¹⁴Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
¹⁵Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy

Nicholas J. Haradhvala, PhD^1*, Stephanie Yiu, PhD^2,3*, Sam Sadigh, MD^4,5*, Laura Beckmann, MD^6,7*, Amber Pospistle^1*, Stephanie Deng^6*, Santiago Rivero^6*, Yao Yu Yeo^2,8*, Katie Maurer, MD, PhD^1,5,6, Vignesh Shanmugam, MD^1,4,5, McKayla Van Orden^9*, Wesley S Lu, BS^9*, Shuqiang Li, PhD^1,9*, Kenneth J. Livak, PhD^9*, Huaying Qiu^10*, Yuzhou Chang^10,11*, Ankit Basak^1,12,13*, Alex K Shalek, PhD^1,13,14*, Mikaela M. McDonough^15*, Robert A. Redd, MS^16*, Scott J. Rodig, MD, PhD^4,5,17, Satyen Gohil, MD PhD^18*, Donna S. Neuberg, ScD¹⁶, Catherine J. Wu, MD^1,5,6*, Gad Getz, PhD^1,5,19,20*, Sizun Jiang, PhD^1,2,5,21 and Erin M. Parry, MD, PhD^1,5,6

¹Broad Institute of MIT and Harvard, Cambridge, MA
²Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA
³Wyss Institute at Harvard, Boston, MA
⁴Department of Pathology, Brigham and Women's Hospital, Boston, MA
⁵Harvard Medical School, Boston, MA
⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁷Faculty of Medicine and Cologne University Hospital, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany, Cologne, Germany
⁸Program in Virology, Harvard Medical School, Boston
⁹Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA
¹⁰Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston
¹¹The Ohio State University, Columbus
¹²Institute for Medical Engineering & Science and Department of Chemistry, Massachusetts Institute of Technology, Cambridge
¹³Ragon Institute of Mass General, MIT and Harvard, Boston, MA
¹⁴Institute for Medical Engineering & Science and Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA
¹⁵Dana-Farber Cancer Institute, Boston, MA
¹⁶Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
¹⁷Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA
¹⁸University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹⁹Department of Pathology, Massachusetts General Hospital, Boston, MA
²⁰Krantz Family Center for Cancer Research and Dept. of Pathology, Massachusetts General Hospital, Boston, MA
²¹Department of Pathology, Dana-Farber Cancer Institute, Boston, MA

Yifan Yin^1*, Tomohiro Aoki, MD, PhD², Shinya Rai, MD, PhD¹, Aixiang Jiang, MS^1*, Alexander Xu, PhD^3*, Luke O’Brien, BSc^4*, Jan Delabie, MD, PhD^5*, Lauren Camille Chong, MSc^6*, Stacy Hung, PhD^4*, Akil Merchant, MD³, David W. Scott, MBChB, PhD⁷, Kerry J. Savage, MD, MSc⁴ and Christian Steidl, MD, PhD¹

¹Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
²Princess Margaret Cancer Centre, Toronto, ON, Canada
³Division of Hematology and Cellular Therapy, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA
⁴BC Cancer, Vancouver, BC, Canada
⁵Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
⁶BC Cancer Agency, Vancouver, BC, CAN
⁷Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada

Anu Korula, MD, DM, MRCP^1*, Arun Arunachalam, MD^2*, Uday Kulkarni, MD, MBBS, DM³, Phaneendra Venkateswara Rao Datari, MD^2*, Sumith Mathew, MD^4*, Aswin Anand PAI, MSc^5*, Sushil Selvarajan, MD, DM^3*, Fouzia N., MD, DM^2*, Aby Abraham, MD, DM^3*, Biju George, MD, DM³, Poonkuzhali Balasubramanian, MSc, PhD^2* and Vikram Mathews, MD⁶

¹Department of Haematology, Christian Medical College & Hospital, Vellore, India
²Department of Haematology, Christian Medical College, Vellore, India
³Department of Haematology, Christian Medical College Ranipet Campus, Ranipet, India
⁴Department of Clinical Pharmacology, Christian Medical College, Vellore, India
⁵Department of Haematology, Christian Medical College, VELLORE, TAMIL NADU, India
⁶Department of Haematology, Christian Medical College, Vellore, Tamil Nadu, India

Joseph G. Schroers-Martin, MD¹, Andrea Garofalo, BS, BA², Shuyu Shi³, Joanne Soo, MD^4*, Helen Luikart, RN, MSN^5*, Brian J. Sworder, MD, PhD⁶, Jan Boegeholz, MD⁷, Xiaoman Kang, BS^8*, Mari Olsen, BS^2*, Chih Long Liu, PhD^2*, Feng Tian, PhD^2*, Annette Skoda^5*, Gerardo Gamino^5*, Dave Jimil Morales^5*, Kathrin Freystaetter, MD^9*, Sean Agbor-Enoh, MD, PhD^10*, Martin Andreas, MBA, PhD^11*, Dan Chambers, MBBS MRCP FRACP MD^12*, Maria Crespo-Leiro, MD, PhD^13*, Gundeep Dhillon, MBBS^14*, Maryjane Farr, MD^15*, Seth Hollander, MD^16*, Abdallah Kfoury, MD^17*, Evan Kransdorf, MD, PhD^18*, Marcel Nijland, MD, PhD^19*, Jayant Raikhelkar, MD^20*, David Rosenthal, MD^21*, Heather Ross, MD^22*, Stijn Verleden, PhD^23*, Lorenzo Zaffiri, MD, PhD^18*, Andreas Zuckermann, MD^9*, David Kurtz, MD, PhD^2,24, Yasodha Natkunam, MD, PhD²⁵, Maximilian Diehn, MD, PhD^26,27*, Kiran Khush, MD^5* and Ash A. Alizadeh, MD, PhD²⁸

¹Department of Medicine, Division of Oncology and Hematology, Stanford University, Menlo Park, CA
²Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
³Dept. of Bioengineering, Schools of Engineering and Medicine, Stanford, CA
⁴Stanford University, Stanford, CA
⁵Division of Cardiovascular Medicine, Stanford University, Stanford, CA
⁶Division of Hematology and Oncology, University of California, Irvine, Irvine, CA
⁷Divisions of Hematology and Oncology, Stanford University, Stanford, CA
⁸Department of Medicine, Division of Oncology, Stanford University, Stanford, CA
⁹Medical University of Vienna, Vienna, Austria
¹⁰National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
¹¹University of Vienna, Vienna, Austria
¹²University of Queensland, Brisbane, Australia
¹³Universitario A Coruña, La Coruna, Spain
¹⁴Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University, Stanford, CA
¹⁵Heart Failure, Mechanical Circulatory Support and Transplant, UT Southwestern, Dallas, TX
¹⁶Stanford University, Palo Alto, CA
¹⁷Intermountain Heart Institute, Murray, UT
¹⁸Cedars Sinai Medical Center, Beverly Hills, CA
¹⁹University Medical Center Groningen and University of Groningen, Groningen, Netherlands
²⁰Columbia University, New York, NY
²¹Department of Pediatrics, Division of Cardiology, Stanford University, Stanford, CA
²²Toronto General Hospital, University Health Network, Toronto, Canada
²³Katholieke Universiteit Leuven, Leuven, Belgium
²⁴Department of Medicine (Oncology), Stanford University, Palo Alto, CA
²⁵Department of Pathology, Stanford University School of Medicine, Stanford, CA
²⁶Department of Radiation Oncology, Stanford University, Stanford, CA
²⁷Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA
²⁸Stanford University, San Mateo, CA